Loading...
•
Sep 30, 2024
DaVita Q3 2024 Earnings Report
DaVita's Q3 2024 financial performance was solid, with a focus on providing quality care and resilience in the face of severe storms.
Key Takeaways
DaVita Inc. reported consolidated revenues of $3.264 billion and an operating income of $535 million for the third quarter of 2024. Diluted earnings per share was $2.50, and adjusted diluted earnings per share was $2.59. The company repurchased 2.7 million shares of its common stock at an average price of $147.20 per share.
Consolidated revenues reached $3.264 billion.
Operating income totaled $535 million.
Diluted EPS was $2.50, and adjusted diluted EPS was $2.59.
The company repurchased 2.7 million shares for $406 million.
DaVita
DaVita
DaVita Revenue by Segment
DaVita Revenue by Geographic Location
Revenue by Segment
U.S. dialysis Revenue
CapyFin.comInternational Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
DaVita provided its 2024 guidance, which no longer excludes center closure costs.
Positive Outlook
- Adjusted operating income is expected to be between $1.91 billion and $2.01 billion.
- Adjusted diluted net income per share is projected to be between $9.25 and $10.05.
- Free cash flow is anticipated to range from $950 million to $1.2 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income